CRL – charles river laboratories international, inc. (US:NASDAQ)
Stock Stats
News
3/27
10:11 am
crl
Low
1 Value Stock on Our Buy List and 2 We Turn Down [Yahoo! Finance]
3/17
09:05 am
crl
Low
In Vivo Toxicology Market to Surpass USD 25.90 Billion by 2035; Rising Demand for Drug Safety Assessment and Expanding Biologics Pipeline Driving Market Growth – SNS Insider [Yahoo! Finance]
3/12
09:56 am
crl
Medium
3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
3/11
08:01 pm
crl
Medium
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit [Yahoo! Finance]
3/10
11:02 am
crl
Low
Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand [Yahoo! Finance]
2/18/2026
07:00 am
CRL
-0.3%
BEAT
11/5/2025
07:00 am
CRL
-5.8%
BEAT
8/6/2025
07:00 am
CRL
-11.6%
BEAT
5/7/2025
07:01 am
CRL
13.2%
BEAT
2/25
03:15 pm
Maintains
Neutral
Neutral
UBS
Low
-0.1%
2/20
11:12 am
Maintains
Neutral
Neutral
Mizuho
Low
1.0%
2/20
11:12 am
Maintains
Neutral
Neutral
Mizuho
Low
1.0%
2/19
10:51 am
Maintains
Overweight
Overweight
Barclays
Medium
4.2%
2/19
10:51 am
Maintains
Overweight
Overweight
Barclays
Medium
4.2%
3/26
05:16 pm
crl
Medium
Form SCHEDULE 13G/A CHARLES RIVER LABORATORI Filed by: VANGUARD GROUP INC
3/5
05:18 pm
crl
Medium
Form 4 CHARLES RIVER LABORATORI For: Mar 04 Filed by: Girshick Birgit
3/4
04:42 pm
crl
Low
Form 4 CHARLES RIVER LABORATORI For: Mar 02 Filed by: FOSTER JAMES C
3/4
04:39 pm
crl
Low
Form 4 CHARLES RIVER LABORATORI For: Mar 03 Filed by: LaPlume Joseph W
2/25
07:34 am
crl
Low
Form 8-K CHARLES RIVER LABORATORI For: Feb 25
Show more
Top News Gainers
2/11 Charles River Laboratories Announces Fourth-Quarter and Full-Year 2019 Results and Provides 2020 Guidance 11.8%
4/3 Immunologist says he has a possible cure for the coronavirus [FOX News] 8.9%
3/2 Charles River Laboratories Intl. Inc (NYSE: CRL) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $190.00 price target on the stock. 4.3%
3/30 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Co from $200.00 to $145.00. They now have an "overweight" rating on the stock. 4.2%
3/4 Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors 4.0%
3/26 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $170.00 to $154.00. They now have an "equal weight" rating on the stock. 3.9%
6/19 Laetose(TM), Healthier Sugar Naturally Modified From Table Sugar, Unveiled at Harvard Health Summit 3.5%
3/10 Charles River Laboratories To Participate In Barclays Global Healthcare Conference 3.2%
2/13 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
11/8 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $147.00 to $145.00. They now have a "neutral" rating on the stock. 2.5%
Top News Decliners
3/19 Doctor says he's 3-4 weeks from developing treatment to 'neutralize' coronavirus [FOX News] -18.6%
4/21 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $139.00 price target on the stock. -6.4%
5/7 Q1/2019 3/30/2019 EPS 1.400 ZacksConsensus 1.380 ActVsEst 0.020 - Beat -5.7%
3/4 Form 3 CHARLES RIVER LABORATORI For: Mar 02 Filed by: Andrews Nancy C -4.9%
7/31 Q2/2019 6/29/2019 EPS 1.630 ZacksConsensus 1.550 ActVsEst 0.080 - Beat -4.5%
10/21 Charles River Laboratories Announces Offering of $500 Million of Senior Notes -4.4%
3/17 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at SunTrust Banks, Inc. from $188.00 to $124.00. They now have a "buy" rating on the stock. -4.0%
9/9 Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio -3.7%
10/1 Charles River Laboratories Adds Virginia M. Wilson to Board of Directors -3.2%
3/27 Charles River Laboratories Intl. Inc (NYSE: CRL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $152.00 price target on the stock. -2.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3